Get started
Author

Ekaterina Е. Mishina

Observed names: E. E. Mishina, E.E. Mishina, Ekaterina E. Mishina, Ekaterina Evgenyevna Mishina, Ekaterina Mishina, Е. Е. Мишина, Е.Е. Мишина, Екатерина Евгеньевна Мишина, Мишина Екатерина Евгеньевна
Observed institution: Endocrinology Research Center
ORCID: 0000-0002-5371-8708
Observed ORCID: 0000-0002-5371-8708
OpenAlex ID: A5053457517
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
2022 · V. T. Ivashkin, M. V. Maevskaya, et al. · Russian Journal of Gastroenterology Hepatology Coloproctology · 88
PDF
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
2022 · Marina V. Maevskaya, Yulia V. Kotovskaya, et al. · Terapevticheskii arkhiv · 67
PDF
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
2025 · V. T. Ivashkin, O. M. Drapkina, et al. · Russian Journal of Gastroenterology Hepatology Coloproctology · 29
PDF
Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
2018 · Apollinariya V. Bogolyubova, Alexander Y. Mayorov, et al. · Diabetes Mellitus · 27
PDF
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
2017 · Ekaterina E. Mishina, Alexander Y. Mayorov, et al. · Diabetes Mellitus · 19
PDF
Алгоритмы специализированной медицинской помощи больным сахарным диабетом
2025 · N.G. Mokrysheva, E.N. Andreeva, et al. · 11
PDF
Genetic Aspects of Non-Alcoholic Fatty Liver Disease
2019 · Pavel O. Bogomolov, Kseniya Yu. Kokina, et al. · Вопросы современной педиатрии · 9
PDF
Evaluation of biosimilarity of RinGlar® (GEROPHARM LLC, Russia) and Lantus® (Sanofi-Aventis Deutschland GmbH, Germany) using the euglycemic hyperinsulinemic clamp technique in patients with type 1 diabetes: double-blind randomized clinical trial
2020 · Alexander Y. Mayorov, Roman V. Drai, et al. · Diabetes Mellitus · 7
PDF
Association of insulin resistance and non-alcoholic fatty liver disease
2021 · Ekaterina E. Mishina, Alexander Y. Mayorov, et al. · Diabetes Mellitus · 2
PDF
Preliminary results of dulaglutide treatment in patients with non-alcoholic fatty liver disease (DEMOS study)
2020 · P. O. Bogomolov, A. O. Bueverov, et al. · Экспериментальная и клиническая гастроэнтерология · 2
PDF
A look at new therapeutic opportunities in patients with non-alcoholic fatty liver disease
2019 · Ekaterina E. Mishina, Alexander Y. Mayorov, et al. · Obesity and metabolism · 2
PDF
Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
2019 · Alexander Y. Mayorov, Ekaterina O. Koksharova, et al. · Diabetes Mellitus · 2
Pathogenetic substantiation of approaches to the treatment of non-alcoholic fatty liver disease.
2018 · P. O. Bogomolov, M. V. Macievich, et al. · Clinical Medicine (Russian Journal) · 2
Результаты двойного слепого рандомизированного сравнительного перекрёстного исследования фармакокинетики и фармакодинамики препаратов генно-инженерного инсулина человека
2019 · Майоров Александр Юрьевич, Авдеева Ольга Ильинична, et al. · CyberLeninK (CyberLeninka) · 1
PDF
Influence of hyperinsulinemic – hypoglycemic clamp on induced platelet aggregation, activity of physiological anticoagulants and von Willebrand factor in patients with type I diabetes
2018 · Iwona R. Jarek-Martynowa, Mikhail Y. Martynov, et al. · Diabetes Mellitus · 1
PDF
To the 110 anniversary since the birth of professor E.A.Vasyukova
2015 · Alexandr Sergeevich Ametov, Elena Valerievna Doskina, et al. · Diabetes Mellitus · 1
The effect of AntiAGE-Biom probiotic on metabolic features in individuals with type 2 diabetes
2025 · Ekaterina A. Shestakova, Anastasiia V. Nosova, et al. · Terapevticheskii arkhiv
PDF
Hereditary lipodystrophies: how not to miss the diagnosis?
2025 · N. V. Frolkova, E. O. Koksharova, et al. · Diabetes Mellitus
PDF
SUN-253 The Impact of Mibavademab, a Novel Leptin Receptor Agonist, on Metabolic Parameters in Individuals with Generalized Lipodystrophy
2025 · Rebecca J Brown, Odelya Pagovich, et al. · Journal of the Endocrine Society
PDF
Роль Фарнезоидного X Рецептора В Патогенезе Неалкогольной Жировой Болезни Печени
2024 · Е. Е. Мишина · Конференция по лечению и диагностике сахарного диабета «Фундаментальная и клиническая диабетология в 21 веке: от теории к практике»
PDF
Влияние Степени Инсулинорезистентности На Прогрессирование Неалкогольной Жировой Болезни Печени
2021 · ФГБУ «НМИЦ эндокринологии» Минздрава России, Е.Е. Мишина, et al.
PDF
Expression of Tlr2, Tlr3, Tlr4 and Proinflammatory Tnf and Il-6 Cytokines in Liver Biopsies of Nonalcoholic Fatty Liver Disease Patients
2019 · A. V. Bogolyubova, E. E. Mishina, et al. · Medical Immunology (Russia)
Acute insulin-induced hypoglycemia decreases systemic fibrinolytic balance in patients with type 1 diabetes
2018 · Karina Sarkisova, Iwona Renata Jarek-Martynowa, et al. · Endocrine Abstracts
Неалкогольная жировая болезнь печени: причина или следствие инсулинорезистентности?
2017 · Мишина Екатерина Евгеньевна, Майоров Александр Юрьевич, et al. · Сахарный диабет
Патогенетическое обоснование подходов к лечению неалкогольной жировой болезни печени
2017 · Pavel Bogomolov, М. В. Мациевич, et al. · CyberLeninK (CyberLeninka)
Works count: 27
Citation count: 270
H-index: 7
I10-index: 6
Year
Topic
Type